在狼中,IL-4会改变TLR7诱导的B细胞发育程序
Changming Lu1, Shanrun Liu1, Min Gao2
1Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Clinical immunology (Orlando, Fla.)
|March 11, 2025
概括
干白素-4 (IL-4) 疗法通过重新编程B细胞发育来减少系统性红斑狼 (SLE) 中的自身抗体. 这种疗法可以抵消与SLE病变有关的托尔类受体7 (TLR7) 驱动的B细胞群.
科学领域:
- 免疫学 免疫学 免疫学
- 这是一种自身免疫力.
- B细胞生物学B细胞生物学
背景情况:
- 收费类受体7 (TLR7) 的刺激通过特定的B细胞子集驱动系统性红斑狼 (SLE) 中的自身抗体的产生.
- 双阴性2 (DN2) B细胞,特征为T-bet+CD11c+IgD-CD27-,是这一致病过程中的关键参与者.
研究的目的:
- 为了研究INTERLEUKIN-4 (IL-4) 在SLE中调节TLR7诱导的B细胞反应中的治疗潜力.
- 在TLR7激活的背景下,确定IL-4如何影响B细胞的发育和表型.
主要方法:
- 将IL-4给自免疫BXD2小鼠,这些小鼠接受了TLR7主激素R848.8的治疗.
- 单细胞转录组学分析以评估B细胞种群和基因表达.
- 用DN2极化尾酒和IL-4进行SLE患者B细胞的体外刺激.
主要成果:
- 在小鼠中,IL-4治疗显著降低了自身抗体和致病性T-bet+CD11c+IgD-B细胞.
- IL-4将B细胞的发育重定向到毛囊,CD23+生殖中心 (GC) 和DN4类记忆B细胞.
- 在SLE患者的B细胞中,IL-4抑制了R848诱导的GCB细胞增殖,并减少了干扰素反应基因.
结论:
- 在SLE模型中,IL-4的使用有效地对抗TLR7驱动的DN2和GCB细胞群.
- IL-4促进B细胞的发育重编程,为SLE提供了潜在的治疗策略.
相关概念视频
T Cell Types and Functions
756
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
756
B Cell Activation and Differentiation
1.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.4K


